|
News feeds |
|
MedPage Today Infectious Disease
|
Physicians.....get the latest breaking news on Infectious Disease. Free CME, accredited by the University of Pennsylvannia, is available for physicians and other medical professionals.
|
-
Reports Alert FDA to Possible Contamination
(MedPage Today) -- Over a seven-month period, manufacturers and distributors have reported 125 food safety issues directly to the FDA, most concerning Salmonella or allergens, the agency said.
-
AAP Updates Head Lice Guidance (CME/CE, with video)
(MedPage Today) -- Children should not be kept home from school because they have head lice, the American Academy of Pediatrics (AAP) reaffirmed.
-
IAC: Circumcision Protects Against HIV Over Long Term (CME/CE)
VIENNA (MedPage Today) -- Male circumcision appears to be protective against HIV for at least four and a half years, a researcher said here.
-
IAC: Novel HIV Drug Offers Speedy Action (CME/CE)
VIENNA (MedPage Today) -- A novel integrase inhibitor -- which blocks a key step in HIV replication -- produced a quicker response than a standard first-line drug in early clinical trials, a researcher said here.
-
IAC: Pre-Exposure Prophylaxis Against HIV Found Safe (CME/CE)
VIENNA (MedPage Today) -- Treating men at high risk of HIV with an antiretroviral drug -- as a preventive measure while they remain HIV-negative -- appears to be safe, a researcher said here.
-
IAC: No Gain in Treating Patients with High CD4 Counts (CME/CE)
VIENNA (MedPage Today) -- Researchers suggest that using antiretroviral therapy in patients with CD4-positive cell counts of more than 500 cells/microliter has limited benefit.
-
CDC Confirms Danger in Airborne Fungal Infection
(MedPage Today) -- With 60 cases of Cryptococcus gattii infection reported through July 1 in the northwestern U.S., the fungus has become enough of a danger that clinicians should be alert for it, according to the CDC.
-
IAC: CD4 Cell Nadir Predicts Dementia (CME/CE)
VIENNA (MedPage Today) -- The risk for neurocognitive impairment in persons living with human immunodeficiency virus (HIV) appears to be inversely proportionate to the level of CD4-positive cells, so those with lowest levels of CD4-positive cells have the greatest risk, researchers said here.
-
IAC: Earlier HIV Therapy Saves Lives in All Locales (CME/CE)
VIENNA (MedPage Today) -- Even in impoverished, resource-challenged settings, earlier initiation of highly active antiretroviral therapy for people infected with the human immunodeficiency virus proves lifesaving, researchers said here.
-
IAC: Two-Drug Combo Effective in Pilot Study (CME/CE)
VIENNA (MedPage Today) -- Once-daily dosing of maraviroc (Selzentry), a cell entry inhibitor, with the boosted protease inhibitor atazanavir (Reyataz) may be sufficient to suppress human immunodeficiency virus (HIV) among treatment naive patients, according to results from a pilot study.
|
|
News feeds 
